Skip to content
Screener

UnitedHealth Group UNH Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

Humana logo
HumanaHUM
$64M+4.9%
DaVita logo
DaVitaDVA
$279.16M+7.1%
Centene logo
CenteneCNC
$72M-16.3%
IQVIA logo
IQVIAIQV
$130M+1,525%
Oscar Health logo
Oscar HealthOSCR
$3.13M+6.5%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$55.74M+10.0%

Other financials

Income statement

See full
Revenue$112.03B+0.4%
Gross profit$98.7B+0.1%
Operating income$8.0B+55.2%
Net income$5.5B+61.0%
EPS (diluted)$6.04+61.5%

Balance sheet

See full
Cash & equivalents$28.6B0.0%
Total debt$73.3B-7.4%
Total equity$104.51B+4.0%
Total assets$309.73B+0.4%

Cash flow

See full
Operating cash flow$11.1B+53.8%
CapEx$799.0M-9.8%
Free cash flow$10.3B+62.7%

Valuation

See full
Market cap$369.69B+61.5%
Enterprise value$414.43B+48.3%
P/E26.2×+15.4×
P/S0.8×+0.3×

Profitability

See full
Gross margin88.6%+0.3pp
Operating margin4.8%-2.5pp
Net margin3.1%-1.9pp
FCF margin5.2%-0.7pp

Returns & leverage

See full
Return on equity13.8%-8.0pp
Debt / equity0.7×-0.1×
Current ratio0.8×-0.1×

Where this comes from

Reported directly by UnitedHealth Group in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: UnitedHealth Group’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000731766-26-000197
(in millions, except per share data)June 30,2026December 31,2025
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding
Common stock, $0.01 par value - 3,000 shares authorized; 905 and 906 issued and outstanding99
Additional paid-in capital559
Retained earnings100,95795,603
Accumulated other comprehensive loss(2,519)(2,061)
Nonredeemable noncontrolling interests6,0665,980
Total equity104,513100,090
Total liabilities, redeemable noncontrolling interests and equity$309,727$309,581

Item 1. Financial Statements (unaudited)

FAQ

What is UnitedHealth Group's noncontrolling interests in subsidiaries?
UnitedHealth Group (UNH) reported noncontrolling interests in subsidiaries of $6.07B in Q2 2026.
How has UnitedHealth Group's noncontrolling interests in subsidiaries changed year-over-year?
UnitedHealth Group's noncontrolling interests in subsidiaries increased by 5.6% year-over-year, from $5.75B to $6.07B.
What is the long-term trend for UnitedHealth Group's noncontrolling interests in subsidiaries?
Over 5 years (2020 to 2025), UnitedHealth Group's noncontrolling interests in subsidiaries has grown at a 16.1% compound annual growth rate (CAGR), from $2.84B to $5.98B.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.

Ask your AI about UnitedHealth Group's noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude